Skip to product information
1 of 1

Elabscience

SKU:E-AB-FC0003-50Tests

Anti-Human CD3-FITC/CD4-PE/CD45-PerCP-Cyanine5.5[OKT3,RPA-T4,HI30]

Anti-Human CD3-FITC/CD4-PE/CD45-PerCP-Cyanine5.5[OKT3,RPA-T4,HI30]

Regular price $200.00 USD
Regular price Sale price $200.00 USD
Sale Sold out
Shipping calculated at checkout.
Size
Introducing the ANTI-HUMAN CD3-FITC/CD4-PE/CD45-PERCP-CYANINE5.5 [OKT3, RPA-T4, HI30], a cutting-edge product designed to revolutionize the field of immunology. This meticulously crafted solution combines the power of three essential antibodies, CD3-FITC, CD4-PE, and CD45-PERCP-CYANINE5.5, to provide unparalleled accuracy and efficiency in cellular analysis.

With a generous size of 50 tests, this product offers an ample supply to cater to your research needs. Each test is meticulously calibrated to ensure consistent and reliable results, allowing for precise identification and characterization of human CD3, CD4, and CD45 markers.

The inclusion of OKT3, RPA-T4, and HI30 antibodies further enhances the versatility of this product, enabling comprehensive analysis of T-cell subsets and lymphocyte populations. The CD3-FITC antibody specifically targets the CD3 antigen, while the CD4-PE antibody binds to the CD4 antigen, and the CD45-PERCP-CYANINE5.5 antibody recognizes the CD45 antigen. This trifecta of antibodies ensures a comprehensive and accurate assessment of cellular phenotypes.

Crafted with utmost precision and utilizing state-of-the-art technology, this product guarantees exceptional performance and reproducibility. Its compatibility with various flow cytometry platforms further enhances its usability, making it an indispensable tool for researchers and clinicians alike.

In summary, the ANTI-HUMAN CD3-FITC/CD4-PE/CD45-PERCP-CYANINE5.5 [OKT3, RPA-T4, HI30] is a game-changing solution that offers unmatched accuracy and efficiency in cellular analysis. With its generous size of 50 tests, meticulous calibration, and compatibility with various flow cytometry platforms, this product is poised to revolutionize the field of immunology.
View full details